conference programme

Understanding breast cancer complexity to improve patients outcomes

scientific programme quick-links

> Wednesday, 15 March 2023

> Thursday, 16 March 2023

> Friday, 17 March 2023

> Saturday, 18 March 2023

> Wednesday, 15 March 2023

> back to top

> Thursday, 16 March 2023

> back to top

> Friday, 17 March 2023

> back to top

> Saturday, 18 March 2023

> back to top

St.Gallen International Consensus on the primary treatment of individuals with breast cancer

As per tradition, the SGBCC 2023 concluded with an update on the widely acknowledged „St. Gallen International Consensus on the Primary Treatment of Individuals with Early Breast Cancer.“ 

The list of the St.Gallen International Breast Cancer Consensus Panel 2023 can be found here.

Publication 2023

The St.Gallen Consensus and its related core issues will be published just a few months after the conference.

Publication 2021

Customizing local and systemic therapies for women with early breast cancer: The St.Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

H.J. Burstein, G. Curigliano, B. Thürlimann, W.P. Weber, P. Poortmans, M. Regan, H.J. Senn, E.P. Winer, M. Gnant and Panelists of the St.Gallen Consensus Conference.

Publication 2019:

Estimating the benefits of therapy for early-stage breast cancer: read the St.Gallen International Consensus Guidelines for the Primary therapy of early breast cancer 2019 here.

chairs

Meet our chairs:

Conference co-chairs
Univ. Prof. Dr. Michael Gnant, Medical University of Vienna / Austria
Prof. Dr. med. Beat Thürlimann, Breast Centre, Kantonsspital St.Gallen / Switzerland
Prof. Dr. Walter Weber, University Hospital Basel / Switzerland

Photo: SGBCC 2023 Opening Ceremony. From left to right: W. Weber, M. Gnant, B. Thürlimann

Scientific Programme-Planning Committee
Harold Burstein, Boston, USA
Giuseppe Curigliano, Milano/Italy
Michael Gnant, Vienna/Austria
Sibylle Loibl, Neu-Isenburg/Germany
Philip Poortmans, Antwerp/Belgium
Meredith Regan, Boston, USA
Hans-Jörg Senn (✝), St.Gallen/Switzerland
Beat Thürlimann, St.Gallen/Switzerland
Walter Weber, Basel/Switzerland
Eric Winer, New Haven, USA

Conference founder and honorary chair
Prof. Dr. med. Hans-Joerg Senn (* 28 March 1934, ✝ 13 January 2023), Foundation St.Gallen Oncology Conferences (SONK), St.Gallen / Switzerland

faculty members

Conflict of Interest Statements

All faculty members of the scientific programme have submitted a conflict of interest statement.
The summary of all statements is available here.

.

subject to changes

abstracts

We have received and reviewed all submitted abstracts over the course of the past couple of months and we could not be more delighted about all the contributions! 

accepted abstract

The list of all accepted abstracts can be found here.

During the conference all accepted submissions can be viewed as e-posters in the e-poster area and via the congress app. 

book of abstracts

All accepted abstracts have been published in an electronic supplement issue to the journal “The Breast” by Elsevier Publishers. Click here to access the journal. 

best poster awards 2023

A renowned reviewing team honours the three best poster abstracts with the St.Gallen Oncology Conferences Best Poster Award 2023. The awards were presented at the SGBCC 2023 on Wednesday, 15 March 2023.

SGBCC Academy

The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world

The SGBCC 2023 was a great success, bringing together leading experts in the field of breast cancer from around the world to share the latest research, best practices, and insights. The conference featured a range of engaging sessions, including keynote lectures, panel discussions, and interactive workshops, covering a broad range of topics related to breast cancer.

One of the highlights of the conference was the SGBCC Academy, which offered a series of lectures on the most important topics in early breast cancer care, delivered by the panelists of the St. Gallen Consensus. Attendees had the opportunity to access these lectures via the virtual conference platform and participate in daily SGBCC Academy sessions, where they could ask follow-up questions and engage in further discussions on the most pressing issues in patient care.

Looking ahead, we are excited to continue providing exceptional educational opportunities to our attendees. We invite you to mark your calendars for the next St. Gallen International Breast Cancer Conference, which will take place in Vienna from 12 – 15 March 2025. Stay tuned for updates and announcements about the program and speakers, and we look forward to seeing you there.

award winners

St.Gallen International Breast Cancer Award Winner 2023

The Foundation Council of “St.Gallen Oncology Conferences“ (SONK) honors Professor Giuseppe Viale for his extraordinary contribution in research and practice development in the treatment of individuals with breast cancer with the “St.Gallen International Breast Cancer Award 2023“, which was presented during the SGBCC 2023 on 15 March 2023.

Prof. Giuseppe Viale
European Institute of Oncology IRCCS, Milan / Italy

St.Gallen Oncology Conferences (SONK) is privileged to count on Prof. Giuseppe Viale as an active contributor and supporter of the St.Gallen International Breast Cancer Conference and Consensus Guidelines. He is the first pathologist to receive this Award. He added his scientific and professional perspective to provide truly interdisciplinary discussions for the benefit of the best treatment of individuals with early breast cancer. With the St.Gallen Breast Cancer Award 2023, the Foundation St.Gallen Oncology Conferences (SONK) wishes to honour Giuseppe Viale for his extraordinary contributions to breast cancer science.

Find out more about Prof. Giuseppe Viale.

ESO Umberto Veronesi Memorial Award Winner 2023

The European School of Oncology (ESO) honors Professor Benjamin Anderson with the “ESO Umberto Veronesi Memorial Award 2023“, which was presented  during the SGBCC 2023 on 15 March 2023.

Prof. Benjamin Anderson
World Health Organization (WHO), Geneva / Switzerland

Ben Anderson, faculty portrait at the Fred Hutchinson Cancer Research Center, May 24, 2019, in Seattle, Washington. 

Find out more about Prof. Benjamin Anderson

Former St.Gallen International Breast Cancer Award Winners

2021:  Prof. Philip Poortmans, Wilrijk-Antwerp/BE

2019:  Prof. Monica Morrow, New York/USA

2017:  Prof. Martine Piccart-Gebhart, Brussels/BE

2015:  Prof. Alan Coates, Cennential Park/AUS

2013:  Prof. Aron Goldhirsch, Lugano/CH + Milano/IT

2011:  Prof. V. Craig Jordan, Washington, DC/USA

2009:  Prof. Richard Gelber, Boston, MA/USA

2007:  Prof. Michael Baum, London/UK

2005:  Prof. Umberto Veronesi, Milano/IT

2003:  Dr. Gianni Bonadonna, Milano/IT and Dr. Bernard Fisher, Pittsburg, PA/USA

Certificate of attendance / CME credit points

The conference counts for 20 CME credit points from the ACOE and UEMS and is also recognised by the international equivalents. 

In order to obtain your certificate of attendance, SONK requires feedback on its educational and organisational activities. Following the conference, we kindly ask all SGBCC 2023 participants to complete an online evaluation which was sent to you by e-mail after the conference. The certificate of attendance will be sent to you after completion of the online evaluation. 

webcasts

We are pleased to announce that the webcasts of the St. Gallen International Breast Cancer Conference 2023 will be exclusively available to participants for the next 6 months, providing you with the opportunity to review and revisit the sessions that matter most to you. After this period, the webcasts will be made publicly accessible for everyone to benefit from.

Click here to view the webcasts of the SGBCC 2023.

The password to access the webcasts have been sent to all participants by e-mail.

We hope that these recordings will help you further enhance your knowledge and understanding of the latest developments in the field of breast cancer. Thank you for being a part of SGBCC 2023!

Click on the links below to view the webcasts of the St.Gallen International Breast Cancer Conferences of the previous years:

• Webcasts SG-BCC 2021
• Webcasts SG-BCC 2019
• Webcasts SG-BCC 2017

We thank our sponsors and partners who support the 18^th St.Gallen International Breast Cancer Conference 2023.

co-operating partners

sponsors and exhibitors

promotional partners

As of today, the industry support of SGBCC 2023 is EUR 1,001,090.00.

satellite symposia programme

Wednesday, 15 March 2023 | 11:30-12:30

Improve patient care with genomic testing to tailor adjuvant systemic treatment in early HR+, HER2- breast cancer

• Welcome + opening remarks – Valentina Guarneri (Italy)
• Genomic testing – where do we stand in terms of clinical evidence? – Valentina Guarneri (Italy)
• Identifying patients for Oncotype DX® testing in my clinical practice – Christos Markopoulos (Greece)
• Patient’s awareness and understanding of genomic testing– Richard Simcock (UK)
• Panel discussion and Q+A

back to top

Thursday, 16 March 2023 | 08:00-08:45 CET 

Industry session organized by Medscape Oncology Global
Supported by an independent educational grant from Lilly

Conceptualizing Guidelines to Manage Patients with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer

• Welcome and Introductions – Sara Tolaney (United States)
• Understanding Hormone Receptor-Positive, HER2-Negative Early Breast Cancer Treatment Guidelines – Giuseppe Curigliano (Italy), Sara M. Tolaney (United States)
• What If: A Case Review Exploring Clinical Decision-Making and Patient Management – Giuseppe Curigliano (Italy), Sara M. Tolaney (United States)
• Managing Adjuvant Therapy – Giuseppe Curigliano (Italy), Sara M. Tolaney (United States)
• Q&A – Giuseppe Curigliano (Italy), Sara M. Tolaney (United States)

back to top

Thursday 16 March 11:30-12:30 CET

The Rise of CDK4/6 Inhibitors in HR+/HER2− Early Breast Cancer: Impact For Patients       
Chair: Peter A. Fasching (Germany)

Faculty: Eva Ciruelos (Spain)

• Welcome and Introduction – Peter A. Fasching (Germany)
• Unmet need and CDK4/6 inhibitors in HR+/HER2− early breast cancer – Eva Ciruelos (Spain)
• QOL and treatment adherence in the adjuvant setting – Peter A. Fasching (Germany)
• Closing and Key Takeaways – Peter A. Fasching (Germany)
• Live Q&A – All

back to top

Friday, 17 March 2023, 11:30-12:30 CET

Advances in HER2-expressing breast cancer treatment with antibody-drug conjugates (ADCs): From metastatic to early disease

Chair: Giuseppe Curigliano (Italy)

• Welcome and introduction – Giuseppe Curigliano (Italy)
• How next-generation ADCs impact outcomes in HER2-expressing metastatic breast cancer – Barbara Pistilli (France)
• Translating clinical experience with ADCs from HER2-positive metastatic breast cancer into the early disease setting – Javier Cortés (Spain)
• Expanding the use of ADCs in HER2-low early breast cancer: What are the key considerations? – Nadia Harbeck (Germany)
• Panel discussion – All faculty
• Wrap up and close – Giuseppe Curigliano (Italy)

back to top

Friday, 17^th March 2023; 17:45–18:45 CET

Solving the puzzle: Tailoring treatment options in early breast cancer

• Welcome and introductions – Nadia Harbeck (Germany)
• Building on the biology: What has changed in the understanding of early breast cancer? – Nadia Harbeck (Germany)
• Sequencing in the spotlight: Making sense of new treatment options – Andrew Tutt
• Completing the picture: Multidisciplinary insights for the treatment of patients with eBC – Peter Dubsky, Carlos Barrios
• Panel discussion – All faculty
• Meeting close – Nadia Harbeck (Germany)

back to top

contact

St. Gallen Oncology Conferences (SONK)
Rorschacherstrasse 150
9006 St.Gallen / Switzerland
+41 71 243 09 90
sgbcc@oncoconferences.ch

newsletter

Stay tuned and register now for the newsletter of the St.Gallen International Breast Conference 2023 or join us on social media!